Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1878-7479
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease ; day:24 ; month:1 ; year:2022 ; pages:1-20
Neurotherapeutics ; (24.1.2022), 1-20

Creator
Palmas, Maria Francesca
Ena, Anna
Burgaletto, Chiara
Casu, Maria Antonietta
Cantarella, Giuseppina
Carboni, Ezio
Etzi, Michela
Simone, Alfonso De
Fusco, Giuliana
Cardia, Maria Cristina
Lai, Francesco
Picci, Luca
Tweedie, David
Scerba, Michael T.
Coroneo, Valentina
Bernardini, Renato
Greig, Nigel H.
Pisanu, Augusta
Carta, Anna R.
Contributor
SpringerLink (Online service)

DOI
10.1007/s13311-022-01182-2
URN
urn:nbn:de:101:1-2022050421152431133372
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Palmas, Maria Francesca
  • Ena, Anna
  • Burgaletto, Chiara
  • Casu, Maria Antonietta
  • Cantarella, Giuseppina
  • Carboni, Ezio
  • Etzi, Michela
  • Simone, Alfonso De
  • Fusco, Giuliana
  • Cardia, Maria Cristina
  • Lai, Francesco
  • Picci, Luca
  • Tweedie, David
  • Scerba, Michael T.
  • Coroneo, Valentina
  • Bernardini, Renato
  • Greig, Nigel H.
  • Pisanu, Augusta
  • Carta, Anna R.
  • SpringerLink (Online service)

Other Objects (12)

Transmission of alpha-synuclein in Parkinson’s disease

Transmission of alpha-synuclein in Parkinson’s disease

Transmission von Alpha-Synuclein beim Morbus Parkinson

Hochschulschrift

Transmission von Alpha-Synuclein beim Morbus Parkinson

Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease

Hochschulschrift

Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease

Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease

Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease

Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles

Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease

The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease

Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease

Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease

Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease

Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease

Related objects